| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
i-ii
|
|
|
|
Award pages
|
|
iii-vi
|
|
|
|
Contents
|
|
viii
|
|
| Platinum Priorities |
| Review Articles and Original Articles together with the Full Length Editorials |
| Prostate Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
International Variation in Prostate Cancer Incidence and Mortality Rates
14 March 2012
Abstract: Context: Wide variation exists internationally for prostate cancer (PCa) rates due to differences in detection practices, treatment, and lifestyle and genetic factors. Objective: We present ...
|
Melissa M. Center,
Ahmedin Jemal,
Joannie Lortet-Tieulent,
Elizabeth Ward,
Jacques Ferlay,
Otis Brawley,
Freddie Bray
et al.
|
1079-1092
|
|
|
|
Prostate Cancer Epidemic in Sight?
26 March 2012
Every year, usually in the January or February issue of CA: A Cancer Journal for Clinicians, their article on global cancer statistics. For years, this paper has reached record numbers of citations, a...
|
Fritz H. Schröder,
Monique J. Roobol
|
1093-1095
|
|
|
|
High-Risk Prostate Cancer: From Definition to Contemporary Management
27 February 2012
Abstract: Context: High-risk prostate cancer (PCa) is a potentially lethal disease. It is clinically important to identify patients with high-risk PCa early on because they stand to benefit the most f...
|
Patrick J. Bastian,
Stephen A. Boorjian,
Alberto Bossi,
Alberto Briganti,
Axel Heidenreich,
Stephen J. Freedland,
Francesco Montorsi,
Mack Roach,
Fritz Schröder,
Hein van Poppel,
Christian G. Stief,
Andrew J. Stephenson,
Michael J. Zelefsky
et al.
|
1096-1106
|
|
|
|
Thwarting High-risk Prostate Cancer: The Right Treatments for the Right Patients
26 March 2012
Age-adjusted prostate cancer mortality rates have fallen roughly 40% in the United States since the advent of prostate-specific antigen (PSA)–based screening two decades ago . Notwithstanding widely a...
|
Matthew R. Cooperberg
|
1107-1109
|
|
|
|
Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial
06 January 2012
Abstract: Background: The complications of prostate needle biopsy (PNB) are important when considering the benefits and harms of prostate cancer screening. Studies from the United States and Canada ha...
|
Stacy Loeb,
Suzanne van den Heuvel,
Xiaoye Zhu,
Chris H. Bangma,
Fritz H. Schröder,
Monique J. Roobol
et al.
|
1110-1114
|
|
|
|
To Biopsy or Not to Biopsy—Thou Shall Think Twice
10 February 2012
Prostate biopsy—generally considered a safe procedure, although beset by rare and worrisome major complications—has changed quite dramatically over the past two decades, as has the prostate cancer (PC...
|
Alexandre R. Zlotta,
Robert K. Nam
|
1115-1117
|
|
|
|
Reply from Authors re: Alexandre R. Zlotta, Robert K. Nam. To Biopsy or Not to Biopsy—Thou Shall Think Twice. Eur Urol 2012;61:1115–7: Considerations for Prostate Biopsy Decisions
14 March 2012
Our group recently reported an increasing frequency of hospitalizations after prostate biopsy consistent with numerous international studies . This subject has important public health implications be...
|
Stacy Loeb,
Suzanne van den Heuvel,
Xiaoye Zhu,
Chris H. Bangma,
Fritz H. Schroder,
Monique J. Roobol
et al.
|
1117-1118
|
|
|
|
Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism
03 February 2012
Abstract: Background: Previous studies demonstrate that androgen-deprivation therapy (ADT) with gonadotropin-releasing hormone (GnRH) agonists and orchiectomy for prostate cancer (PCa) is associated w...
|
Jim C. Hu,
Stephen B. Williams,
A. James O’Malley,
Matthew R. Smith,
Paul L. Nguyen,
Nancy L. Keating
et al.
|
1119-1128
|
|
|
|
Androgen Deprivation Therapy for Localized and Nonmetastatic Prostate Cancer: Too Much of a Good Thing?
14 March 2012
Unfortunately, no treatment is without risk. It is widely known that the risks of androgen deprivation therapy (ADT) include osteoporosis and fracture risk, hot flashes, sexual dysfunction, changes in...
|
Ramdev Konijeti,
Adam S. Kibel
|
1129-1130
|
|
|
|
Reply from Authors re: Ramdev Konijeti, Adam S. Kibel. Androgen Deprivation Therapy for Localized and Nonmetastatic Prostate Cancer: Too Much of a Good Thing? Eur Urol 2012;61:1129–30: Still Much to Understand About Androgen Deprivation Therapy and Cardiovascular Disease
05 April 2012
We could not agree more with Konijeti and Kibel's central recommendation to limit the use of androgen deprivation therapy (ADT) to patients for whom evidence suggests a clear benefit. We do, however,...
|
Nancy L. Keating,
Matthew R. Smith,
Jim C. Hu
|
1131
|
|
|
|
Performance Characteristics of Computed Tomography in Detecting Lymph Node Metastases in Contemporary Patients with Prostate Cancer Treated with Extended Pelvic Lymph Node Dissection
14 November 2011
Abstract: Background: Computed tomography (CT) is a commonly used noninvasive procedure for prostate cancer (PCa) staging. All previous studies addressing the ability of CT scan to predict lymph node ...
|
Alberto Briganti,
Firas Abdollah,
Alessandro Nini,
Nazareno Suardi,
Andrea Gallina,
Umberto Capitanio,
Marco Bianchi,
Manuela Tutolo,
Niccolò Maria Passoni,
Andrea Salonia,
Renzo Colombo,
Massimo Freschi,
Patrizio Rigatti,
Francesco Montorsi
et al.
|
1132-1138
|
|
|
|
Nodal Staging in Prostate Cancer: Still an Unresolved Issue
29 December 2011
Until now, pelvic lymph node dissection (PLND) has proven to be the most accurate and reliable nodal staging procedure in prostate cancer (PCa), as currently available imaging techniques report low se...
|
Steven Joniau,
Laura Van den Bergh,
Charlotte Peeters,
Karin Haustermans,
Martin Spahn
et al.
|
1139-1141
|
|
| Urothelial Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Laparoscopic Versus Open Nephroureterectomy for the Treatment of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Cumulative Analysis of Comparative Studies
16 February 2012
Abstract: Context: Laparoscopic nephroureterectomy (LNU) has increasingly been used as a minimally invasive alternative to open nephroureterectomy (ONU), but studies comparing the efficacy and safety ...
|
Shaobin Ni,
Weiyang Tao,
Qiyin Chen,
Lianxin Liu,
Hongchi Jiang,
Hailong Hu,
Ruifa Han,
Chunyang Wang
et al.
|
1142-1153
|
|
|
|
Is There Currently Enough Evidence To Assess Whether Laparoscopic Nephroureterectomy Is Safe to Treat Urothelial Carcinoma of the Upper Urinary Tract?
27 February 2012
Whether or not laparoscopic nephroureterectomy (LNU) will play a key role in the future is the subject of ongoing debate. Open nephroureterectomy (ONU) remains the gold standard procedure for the mana...
|
Morgan Rouprêt
|
1154-1155
|
|
| Kidney Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Radiofrequency Ablation Versus Partial Nephrectomy in Patients with Solitary Clinical T1a Renal Cell Carcinoma: Comparable Oncologic Outcomes at a Minimum of 5 Years of Follow-Up
11 January 2012
Abstract: Background: Long-term comparative outcomes for radiofrequency ablation (RFA) versus partial nephrectomy (PN) for the primary treatment of clinical T1a renal cell carcinoma (RCC) have not pre...
|
Ephrem O. Olweny,
Samuel K. Park,
Yung K. Tan,
Sara L. Best,
Clayton Trimmer,
Jeffrey A. Cadeddu
et al.
|
1156-1161
|
|
|
|
Is Radiofrequency Ablation for Small Kidney Tumors Ready for Prime Time?
27 February 2012
Olweny and colleagues compare 5-yr oncologic outcomes of radiofrequency ablation (RFA) and partial nephrectomy (PN) for clinical T1a tumors . Of 140 patients with a solitary renal cell carcinoma (RCC)...
|
Alvin C. Goh,
Inderbir S. Gill
|
1162-1163
|
|
|
|
Reply from Authors re: Alvin C. Goh, Inderbir S. Gill. Is Radiofrequency Ablation for Small Kidney Tumors Ready for Prime Time? Eur Urol 2012;61:1162–3.
14 March 2012
Goh and Gill outlined limitations of our comparative study on long-term outcomes of radiofrequency ablation (RFA) versus partial nephrectomy (PN) for the treatment of solitary, clinical, T1a renal ce...
|
Ephrem O. Olweny,
Jeffrey A. Cadeddu
|
1163-1164
|
|
| Benign Prostatic Hyperplasia |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Photoselective Vaporization of the Prostate with GreenLight 120-W Laser Compared with Monopolar Transurethral Resection of the Prostate: A Multicenter Randomized Controlled Trial
10 February 2012
Abstract: Background: Evidence supporting the widespread use of GreenLight High Performance System (HPS) 120-W photoselective vaporization of the prostate (PVP) is lacking. Objective: To assess the no...
|
Bertrand Lukacs,
Joyce Loeffler,
Franck Bruyère,
Pascal Blanchet,
Albert Gelet,
Patrick Coloby,
Alexandre De la Taille,
Philippe Lemaire,
Jean-Christophe Baron,
Jean-Nicolas Cornu,
Mounir Aout,
Helene Rousseau,
Eric Vicaut,
for the REVAPRO study group
et al.
|
1165-1173
|
|
|
|
After Three Randomised Controlled Trials Comparing 120-W High-Performance-System Potassium-Titanyl-Phosphate Laser Vaporisation to Transurethral Resection of the Prostate (TURP), Is This Procedure Finally First-Line, Outdated, or Still Not Surpassing TURP?
27 February 2012
The intensive search for an effective and safe surgical alternative to conventional transurethral resection of the prostate (TURP) is driven by (1) the well-known side effects and complications of TUR...
|
Stephan Madersbacher
|
1174-1176
|
|
|
|
Reply from Authors re: Stephan Madersbacher. After Three Randomised Controlled Trials Comparing 120-W High-Performance-System Potassium-Titanyl-Phosphate Laser Vaporisation to Transurethral Resection of the Prostate (TURP), Is This Procedure Finally First-Line, Outdated, or Still Not Surpassing TURP? Eur Urol 2012;61:1174–6: Photoselective Vaporization of the Prostate with GreenLight 120-W Laser: Running After Evidence
22 March 2012
The past 15 yr have been marked by the introduction of several new surgical techniques, including lasers, that have been presented as potential alternatives to monopolar transurethral resection of the...
|
Jean-Nicolas Cornu,
Eric Vicaut,
Mounir Aout,
Bertrand Lukacs
|
1176-1177
|
|
| Neuro-urology |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action
03 February 2012
Abstract: Background: OnabotulinumtoxinA (Onabot/A) has been used to treat detrusor overactivity disorders. The treatment is based on several injections of toxin throughout the bladder wall. However, ...
|
Ana Coelho,
Francisco Cruz,
Célia D. Cruz,
António Avelino
|
1178-1184
|
|
|
|
Volume Matters: Bladder Injections of Botulinum Toxin Type A
27 February 2012
OnabotulinumtoxinA at a dose of 200 U is an established second-line treatment of neurogenic detrusor overactivity (NDO) . Many patients refractory to antimuscarinics have been helped by this treatment...
|
Prokar Dasgupta
|
1185-1186
|
|
|
|
Reply from Authors re: Prokar Dasgupta. Volume Matters: Bladder Injections of Botulinum Toxin Type A. Eur Urol 2012;61:1185–6: Yes, Volume Matters: Bladder Injections of Botulinum Toxin Type A
19 March 2012
We greatly appreciated the timely and detailed editorial of Dr. Dasgupta regarding the present and putative future applications of onabotulinumtoxinA (OnabotA) to treat bladder pathologies . Primarily...
|
Ana Coelho,
Francisco Cruz,
Célia D. Cruz,
António Avelino
|
1186-1187
|
|
| Stone Disease |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Percutaneous Nephrolithotomy in the United Kingdom: Results of a Prospective Data Registry
12 January 2012
Abstract: Background: Percutaneous nephrolithotomy (PCNL) is commonly used in the management of large upper renal tract stones. It is highly effective but carries a greater risk of significant morbidi...
|
James N. Armitage,
Stuart O. Irving,
Neil A. Burgess,
for the British Association of Urological Surgeons Section of Endourology
|
1188-1193
|
|
|
|
The Time Is Now—the Ability Is Yours
10 February 2012
Urologists today should be prepared to be asked about their knowledge, activities, achievements, and outcomes in their daily clinical practice. Third parties are already using administrative databases...
|
Jean de la Rosette
|
1194-1195
|
|
|
|
Reply from Authors re: Jean de la Rosette. The Time Is Now—the Ability Is Yours. Eur Urol 2012;61:1194–5: Prospective Data Registries: Opportunities for International Collaboration in Endourology
20 February 2012
We would like to thank de la Rosette for his kind and constructive editorial comments on our paper, “Percutaneous nephrolithotomy in the United Kingdom: results of a prospective data registry” .
|
James N. Armitage,
Stuart O. Irving,
Neil A. Burgess,
for the BAUS Section of Endourology
|
1195-1196
|
|
| Editorials |
| |
Article Title |
Author(s) |
Pages |
|
|
|
European Urology: An American Perspective
30 March 2012
I first became aware of European Urology about 6 yr ago, when I was asked to review a paper for the journal. I agreed and finished my review, and within a week, I was asked to do another review. This ...
|
Stephen J. Freedland
|
1197-1198
|
|
|
|
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder Tumor Checklist
23 March 2012
“Do no harm” is one of the precepts of medicine. However, iatrogenic errors in health care often result in an adverse patient outcome. These errors may occur in the perioperative setting. A large prop...
|
David Pan,
Mark S. Soloway
|
1199-1203
|
|
| Reviews |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Salvage Cryoablation for Locally Recurrent Prostate Cancer Following Primary Radiotherapy
09 March 2012
Abstract: Context: The purpose of this paper is to review current salvage cryoablation (SCA) outcomes in patients with locally recurrent prostate cancer (PCa) following primary radiation therapy. Obje...
|
Vladimir Mouraviev,
Philippe E. Spiess,
J. Stephen Jones
|
1204-1211
|
|
|
|
The Contemporary Role of Chemotherapy for Advanced Testis Cancer: A Systematic Review of the Literature
26 March 2012
Abstract: Context: Germ cell tumours (GCTs) of the testis are the most common cancer in young men; they are also one of the most curable cancers. Standard treatment of metastatic GCTs has evolved on t...
|
Fabio Calabrò,
Peter Albers,
Carsten Bokemeyer,
Chris Martin,
Lawrence H. Einhorn,
Alan Horwich,
Susanne Krege,
Hans Joachim Schmoll,
Cora N. Sternberg,
Gedske Daugaard
et al.
|
1212-1221
|
|
| Surgery in Motion |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Technical Refinement and Learning Curve for Attenuating Neurapraxia During Robotic-Assisted Radical Prostatectomy to Improve Sexual Function
14 March 2012
Abstract: Background: While radical prostatectomy surgeon learning curves have characterized less blood loss, shorter operative times, and fewer positive margins, there is a dearth of studies characte...
|
Mehrdad Alemozaffar,
Antoine Duclos,
Nathanael D. Hevelone,
Stuart R. Lipsitz,
Tudor Borza,
Hua-Yin Yu,
Keith J. Kowalczyk,
Jim C. Hu
et al.
|
1222-1228
|
|
| Bladder Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer
15 December 2011
Abstract: Background: Characterising responders to neoadjuvant chemotherapy (NAC) is important to minimise overtreatment and the unnecessary delay of definitive treatment of urothelial urinary bladder...
|
Robert Rosenblatt,
Amir Sherif,
Erkki Rintala,
Rolf Wahlqvist,
Anders Ullén,
Sten Nilsson,
Per-Uno Malmström,
the Nordic Urothelial Cancer Group
et al.
|
1229-1238
|
|
|
|
Comparative Analysis of Outcomes and Costs Following Open Radical Cystectomy Versus Robot-Assisted Laparoscopic Radical Cystectomy: Results From the US Nationwide Inpatient Sample
05 April 2012
Abstract: Background: Although robot-assisted laparoscopic radical cystectomy (RARC) was first reported in 2003 and has gained popularity, comparisons with open radical cystectomy (ORC) are limited to...
|
Hua-yin Yu,
Nathanael D. Hevelone,
Stuart R. Lipsitz,
Keith J. Kowalczyk,
Paul L. Nguyen,
Toni K. Choueiri,
Adam S. Kibel,
Jim C. Hu
et al.
|
1239-1244
|
|
| Urothelial Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers
19 January 2012
Abstract: Background: DNA methylation markers could serve as useful biomarkers, both as markers for progression and for urine-based diagnostic assays. Objective: Identify bladder cancer (BCa)–specific...
|
Raju Kandimalla,
Angela A.G. van Tilborg,
Lucie C. Kompier,
Dominique J.P.M. Stumpel,
Ronald W. Stam,
Chris H. Bangma,
Ellen C. Zwarthoff
et al.
|
1245-1256
|
|
| Kidney Cancer |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Robotic Versus Laparoscopic Partial Nephrectomy for Complex Tumors: Comparison of Perioperative Outcomes
19 March 2012
Abstract: Background: Recent studies showed that robotic partial nephrectomy (RPN) offered outcomes at least comparable to those of laparoscopic partial nephrectomy (LPN). LPN can be particularly chal...
|
Jean-Alexandre Long,
Rachid Yakoubi,
Byron Lee,
Julien Guillotreau,
Riccardo Autorino,
Humberto Laydner,
Remi Eyraud,
Robert J. Stein,
Jihad H. Kaouk,
Georges-Pascal Haber
et al.
|
1257-1262
|
|
| Words of Wisdom |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Re: Hedgehog/Wnt Feedback Supports Regenerative Proliferation of Epithelial Stem Cells in Bladder
Shin K, Lee J, Guo N, et alNature 2011;472:110–4Experts’ summary:The regeneration of multilayered urinary bladder epithelium that consists of umbrella cells, intermediate cells, and basal cells that s...
|
Martin Vaegler,
Katja Schenke-Layland,
Arnulf Stenzl
|
1263-1264
|
|
|
|
Re: Alkaline Citrate Reduces Stone Recurrence and Regrowth After Shockwave Lithotripsy and Percutaneous Nephrolithotomy
Lojanapiwat B, Tanthanuch M, Pripathanont C, et alInt Braz J Urol 2011;37:611–6Expert's summary:This study is a randomized comparison of patients with residual stone material in the kidney after shock...
|
Hans-Göran Tiselius
|
1264
|
|
|
|
Re: Baseline Prostate-Specific Antigen Testing at a Young Age
Loeb S, Carter HB, Catalona WJ, Moul JW, Schroder FHEur Urol 2012;61:1–7Expert's summary:This paper by Loeb et al was followed by comments from editors and reviewers and these were responded to by the...
|
Ihab Ahmed Hekal
|
1264-1265
|
|
|
|
Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled Trial
Fleshner NE, Lucia MS, Egerdie B, et alLancet 2012;379:1103-11Experts’ summary:Fleshner et al report the results of REDEEM, a 3-yr trial investigating the impact of the 5α-reductase inhibitor (5-ARI) ...
|
Bertrand Tombal,
Frederic Lecouvet
|
1265-1266
|
|
|
|
Re: Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study
Zehnder P, Studer UE, Skinner EC, et alJ Urol 2011;186:1261–8Expert's summary:A retrospective comparison was conducted of 554 cystectomy pT2–3 patients from the University of Southern California (USC)...
|
Henk G. van der Poel
|
1266-1267
|
|
|
|
Re: Can a Durable Disease-Free Survival be Achieved with Surgical Resection in Patients with Pathological Node Positive Renal Cell Carcinoma?
Delacroix SE Jr, Chapin BF, Chen JJ, et alJ Urol 2011;186:1236–41Expert's summary:The authors assessed the outcomes of 68 patients diagnosed with renal cell carcinoma (RCC) (T[any] pN1-2 M0) and treat...
|
Carlo Terrone
|
1267-1268
|
|
| Letters to the Editor published online |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012;61:378–84
22 March 2012
Evidence supports that the range of prognoses among G3T1 bladder cancer cases is wide enough to consider subclasifications. Traditionally, the depth of invasion has been categorized as above the muscu...
|
Anna Orsola,
Inés de Torres,
Juan Morote
|
e53-e54
|
|
|
|
Reply to Anna Orsola, Inés de Torres and Juan Morote's Letter to the Editor re: Bas W.G. van Rhijn, Theo H. van der Kwast, Sultan S. Alkhateeb, et al. A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage. Eur Urol 2012:61:378–84
22 March 2012
Improvement in initial treatment decision making for T1 bladder cancer (BCa) is urgently needed. We lack generally accepted and reliable prognostic markers to recommend radical surgery versus bladder ...
|
Bas W.G. van Rhijn,
Theo H. van der Kwast,
Michael A.S. Jewett,
Alexandre R. Zlotta
|
e55-e56
|
|
|
|
Re: Jens J. Rassweiler, Michael Müller, Markus Fangerau, et al. iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience. Eur Urol 2012;61:628–31
26 March 2012
We congratulate the authors for this innovative technique in which they demonstrate the feasibility of iPad-assisted augmented reality to achieve accurate access for percutaneous nephrolithotomy (PCNL...
|
Swarnendu Mandal,
Apul Goel,
Dheeraj Kumar Gupta
|
e57
|
|
|
|
Reply to Swarnendu Mandal, Apul Goel and Dheeraj Kumar Gupta's Letter to the Editor re: Jens J. Rassweiler, Michael Müller, Markus Fangerau, et al. iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience. Eur Urol 2012;61:628–31
26 March 2012
We can understand your concern about increasing the cost and complexity of percutaneous nephrolithotomy (PCNL) through use of iPad-assisted marker-based navigation . However, there might be a misunder...
|
Jens Rassweiler
|
e58
|
|
|
|
Re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer. Eur Urol 2012;61:11–25
27 February 2012
With great interest, I read the article, “Contemporary role of androgen deprivation therapy for prostate cancer,” in the January 2012 issue of European Urology. I want to make a comment on paragraph 3...
|
Erik B. Cornel
|
e59
|
|
|
|
Reply to Erik B. Cornel's Letter to the Editor re: Vincenzo Pagliarulo, Sergio Bracarda, Mario A. Eisenberger, et al. Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer. Eur Urol 2012;61:11–25
27 February 2012
We appreciate the thoughtful comments by Cornel. Many urologists who believe that pharmaceutical industries have influenced our treatment strategies probably share his concern. Indeed, the preference ...
|
Vincenzo Pagliarulo,
Nicolas Mottet,
Fritz H. Schröder
|
e60
|
|
|
|
Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification. Eur Urol. In press. DOI:10.1016/j.eururo.2012.01.019
26 March 2012
We read the above-mentioned article by Shariat et al. with great interest. The authors should be admired for conducting such a large-scale, multicentre, worldwide study. However, some issues require ...
|
Toyonori Tsuzuki,
Naoto Sassa,
Momokazu Gotoh
|
e61
|
|
| Congress Calendar |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Congress Calendar
|
|
1269-1274
|
|
| Acknowledgement to Reviewers |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Acknowledgement to Reviewers
26 March 2012
|
|
e62-e65
|
|
